Cancer Genomic Profiling
Total Trials
2
As Lead Sponsor
1
As Collaborator
Total Enrollment
638
NCT03719222
Analysis of Tumor Mutations and Tumor Microenvironment Using Archival Paraffin-embedded Tumor Specimens
Phase: N/A
Role: Lead Sponsor
Start: Sep 26, 2018
Completion: Sep 30, 2019
NCT04377048
Nivolumab Adding on Gemcitabine/S-1 in Metastatic Pancreatic Cancer
Phase: Phase 2
Role: Collaborator
Start: Jul 1, 2020
Completion: Dec 31, 2022
Loading map...